Recent changes to clinical trial rules in Europe, an emerging controversy over Food and Drug Administration (FDA)-approved anemia drugs, and heated debate over the bird flu moratorium are all in the mix in this week’s Research Ethics Roundup.
Europe proposes revision of clinical trial rules: The European Commission has formally adopted proposals for new rules to replace the controversial Clinical Trials Directive. Experts predict that these changes will reduce some of the red tape that has resulted in bloated insurance costs and a reduction in the number of clinical trials being conducted in the EU since the inception of the directive.
Natasha Blakeney, MPH, is the training director of the Education Network to Advance Clinical Trials (ENACCT). Founded in 2004, ENACCT is dedicated to improving cancer care and research through clinical trials. In this piece, reprinted from ENACCT’s blog, Natasha shares her perspective on increasing enrollment of African Americans in cancer clinical trials.
The National Cancer Institute (NCI) recently released a video discussing African Americans and their participation in cancer clinical trials. The video highlights some of the well-known challenges affecting this study [...] Read more
As we hurtle towards summer, the research world is heating up! From contentious stem cell policies in Texas, to evidence of potential misdiagnoses in children, this week’s “Science Times” synthesis is full of controversial and eye-opening reports from around the globe.
Week of April 9
More brainpower seen in soccer’s top scorers: A new study finds that elite soccer players in Sweden tested higher than non-players in executive [...] Read more
by Elisa Hurley, PhD, Education Director
Last month, I had the opportunity to attend the second Asia Pacific Research Ethics Conference (APREC), which took place March 7-9 in Singapore. The meeting was organized by the National Healthcare Group (NHG), and PRIM&R was proud to serve as the meeting’s co-sponsor, as we did for [...] Read more